Extended-spectrum beta-lactamases: will they be the new 'methicillin-resistant Staphylococcus aureus'?
Hicks
James A
JA
Solent Department of Urology, St Mary's Hospital, Portsmouth, UK. vjhicks@btopenworld.com
Harris
Mark R E
MR
Keoghane
Stephen R
SR
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004927:Escherichia coli Infections / Q000188:drug therapy* / Q000201:enzymology; D005578:Fosfomycin / Q000627:therapeutic use*; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy* / Q000201:enzymology; D009582:Nitrofurantoin / Q000627:therapeutic use*; D018440:beta-Lactam Resistance; D001618:beta-Lactamases
D000900:Anti-Bacterial Agents; D005578:Fosfomycin; D009582:Nitrofurantoin; D001618:beta-Lactamases